Clinical Trials Browser

Phase 1/2 × Adoptive Transfer × Dermatologic × Clear all

NCT02354690 2020-03-23

Vemurafenib and TIL Therapy for Metastatic Melanoma

Phase 1/2 Completed

13 enrolled 12 charts

Melanoma